Lawrence Kushi to Trastuzumab
This is a "connection" page, showing publications Lawrence Kushi has written about Trastuzumab.
Connection Strength
0.142
-
Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019. Breast Cancer Res. 2024 Jun 13; 26(1):101.
Score: 0.060
-
Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study. J Clin Oncol. 2022 May 20; 40(15):1647-1658.
Score: 0.052
-
Non-initiation and early discontinuation of adjuvant trastuzumab in women with localized HER2-positive breast cancer. Breast Cancer. 2014 Nov; 21(6):780-5.
Score: 0.030